Informa plc (LON:INF – Get Free Report)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 833.61 and traded as high as GBX 909.60. Informa shares last traded at GBX 904.40, with a volume of 9,919,048 shares traded.
Analyst Upgrades and Downgrades
INF has been the subject of a number of research reports. JPMorgan Chase & Co. reduced their price objective on Informa from GBX 1,300 to GBX 1,285 and set an “overweight” rating for the company in a research report on Thursday, July 2nd. Berenberg Bank boosted their price objective on Informa from GBX 965 to GBX 1,040 and gave the stock a “buy” rating in a report on Friday, July 31st. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 1,140 price objective on shares of Informa in a research note on Friday, July 31st. Five equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of GBX 1,095.
Check Out Our Latest Stock Report on INF
Informa Price Performance
Informa (LON:INF – Get Free Report) last announced its earnings results on Thursday, July 30th. The company reported GBX 26.70 EPS for the quarter. Informa had a return on equity of 3.90% and a net margin of 5.43%. As a group, research analysts anticipate that Informa plc will post 59.3240265 earnings per share for the current year.
Insider Transactions at Informa
In other news, insider Stephen A. Carter acquired 222 shares of the firm’s stock in a transaction on Wednesday, May 20th. The stock was purchased at an average price of GBX 809 per share, for a total transaction of £1,795.98. Also, insider Gareth Wright acquired 222 shares of the firm’s stock in a transaction on Wednesday, May 20th. The stock was purchased at an average price of GBX 809 per share, with a total value of £1,795.98. Insiders own 0.24% of the company’s stock.
Informa Company Profile
Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.
We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.
And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.
Further Reading
- Five stocks we like better than Informa
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Informa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Informa and related companies with MarketBeat.com's FREE daily email newsletter.
